RecruitingNot Applicable

Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54

United States1,160 participantsStarted 2021-01-07

Plain-language summary

Low-dose CT Screening has been shown in two large trials in the United States (NLST) and Europe (NELSON) to increase overall survival in subjects 55 years of age and older with a strong smoking history. Unfortunately, in both North Carolina (NC) and South Carolina (SC), subjects are found to have the above referenced smoking history prior to reaching the minimum age in these studies. This study is aimed at decreasing the minimum age of screening in a high-risk population.

Who can participate

Age range40 Years – 54 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Written informed consent and HIPAA authorization for release of personal health information. NOTE: HIPAA authorization may be included in the informed consent or obtained separately.
✓. Age 40-54 years at the time of consent.
✓. A positive smoking history of greater/equal to 30 pack years and they are either currently smoking or have quit within the last 15 years.
✓. Ability to read and understand the English and/or Spanish language.
✓. Ability to understand and comply with study procedures for the entire length of the study.

Exclusion criteria

✕. Known diagnosis of lung cancer in the past 5 years.
✕. Any known contraindication to having a low-dose CT Scan.
✕. Known pregnancy.

What they're measuring

Lung cancer diagnosis rate in individuals 40-54 years of age at their first screening (T0) with mobile low-dose CT.

Timeframe: 1 day

Trial details

NCT IDNCT04577599

SponsorWake Forest University Health Sciences

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2028-10

Contact for this trial

Darcy Doege, RN

913-424-6431 Darcy.Doege@atriumhealth.org

View on ClinicalTrials.gov More Lung Neoplasms trials